Pending EO 12866 Regulatory Review

RIN: 1117-ZA07	Received Date: 11/10/2025
Title: Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Agency/Subagency: DOJ / DEA	Stage: Final Rule
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No